BREXIT: UK Government under pressure to extend assurances to other key industries
June 1, 2017
By Natasha Allen -Great innovation comes from great minds but needs adequate funding to be realized, which requires continued access to the markets in Europe and safeguarding research investment!
AstraZeneca’s influential R&D leader Mene Pangalos has blasted the UK government’s drug watchdog NICE for keeping the price of new drugs at low levels, saying that regulators are threatening the industry’s substantial R&D presence in the country in a post-Brexit world.